The global regulatory architecture governing controlled substances is experiencing an unprecedented structural reconfiguration. For over half a century, international drug control treaties and domestic penal codes categorized entheogenic fungi—specifically the psychoactive alkaloid psilocybin—within the most restrictive prohibitive tiers. These frameworks were built on the strict statutory presumption that the compound possessed an exceptionally high potential […]